FREELINE THERAPEUTICS HOLDIN (FRLN) Stock Balance Sheet
NASDAQ:FRLN - Nasdaq - US35655L2060 - ADR - Currency: USD
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 29.45M | 47.30M | 117.70M | 230.00M | 73.70M | |||
| Receivables | 1.85M | 1.20M | 2.20M | 16.10M | 11.50M | |||
| Other Current Assets | 2.70M | 19.10M | 8.40M | 12.10M | 3.80M | |||
| Total Current Assets | 34.00M | 67.60M | 128.30M | 258.20M | 89.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.55M | 15.00M | 9.90M | 8.60M | 7.30M | |||
| Intangibles | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Assets | 2.67M | 4.00M | 2.90M | 1.80M | 1.00M | |||
| Total Non-Current Assets | 15.22M | 19.00M | 12.80M | 10.40M | 8.40M | |||
| TOTAL ASSETS | 49.22M | 86.60M | 141.10M | 268.60M | 97.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 9.42M | 10.00M | 14.70M | 10.20M | 6.10M | |||
| Accounts Payable | 7.78M | 10.10M | 5.20M | 8.10M | 5.80M | |||
| Other Current Liabilities | 283.00K | 10.90M | 800.00K | 500.00K | 500.00K | |||
| Total Current Liabilities | 17.48M | 31.00M | 20.70M | 18.80M | 12.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.70M | 3.30M | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 1.70M | 3.20M | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 19.18M | 34.20M | 20.70M | 18.80M | 12.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -472.29M | -445.40M | -356.40M | -216.00M | -119.70M | |||
| Additional Paid In Capital | 503.76M | 500.80M | 467.20M | 456.30M | 207.60M | |||
| Common Shares | 137.65K | 100.00K | 100.00K | 200.00K | 0.00 | |||
| Other Shareholders' Equity | -1.57M | -3.20M | 9.50M | 9.30M | -3.00M | |||
| Shares Outstanding | 4.36M | 4.34M | 2.39M | 2.39M | 2.31M | |||
| Tangible Book Value per Share | 0.46 | 0.80 | 3.35 | 6.96 | 2.45 | |||
| Total Shareholders' Equity | 30.04M | 52.40M | 120.40M | 249.80M | 85.00M | |||
| TOTAL LIABILITIES AND EQUITY | 49.22M | 86.60M | 141.10M | 268.60M | 97.40M | |||
| Statistics | ||||||||
| Current Ratio | 1.95 | 2.18 | 6.20 | 13.73 | 7.18 | |||
| Return On Assets (ROA) | -101.44% | -102.74% | -99.50% | -35.86% | -55.35% | |||
| Return On Equity (ROE) | -166.21% | -169.79% | -116.60% | -38.56% | -63.42% | |||
All data in USD , ROIC based on taxRate of 0.21